XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.2
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Sales Revenue by Similar Products (Details) - USD ($)
$ in Millions
4 Months Ended
Jun. 17, 2023
Jun. 18, 2022
Concentration Risk [Line Items]    
Net sales and other revenue $ 24,050.2 $ 23,310.3
Product Line | Product Concentration Risk    
Concentration Risk [Line Items]    
Net sales and other revenue $ 24,050.2 $ 23,310.3
Percentage of total net sales and other revenue 100.00% 100.00%
Non-perishables | Product Line | Product Concentration Risk    
Concentration Risk [Line Items]    
Net sales and other revenue $ 12,086.8 $ 11,446.0
Percentage of total net sales and other revenue 50.30% 49.10%
Fresh | Product Line | Product Concentration Risk    
Concentration Risk [Line Items]    
Net sales and other revenue $ 7,889.3 $ 7,881.5
Percentage of total net sales and other revenue 32.80% 33.80%
Pharmacy | Product Line | Product Concentration Risk    
Concentration Risk [Line Items]    
Net sales and other revenue $ 2,300.1 $ 1,923.5
Percentage of total net sales and other revenue 9.60% 8.30%
Fuel | Product Line | Product Concentration Risk    
Concentration Risk [Line Items]    
Net sales and other revenue $ 1,400.4 $ 1,654.7
Percentage of total net sales and other revenue 5.80% 7.10%
Other | Product Line | Product Concentration Risk    
Concentration Risk [Line Items]    
Net sales and other revenue $ 373.6 $ 404.6
Percentage of total net sales and other revenue 1.50% 1.70%